Why Evidence Matters to Your Clinically Integrated Supply Chain
- Erinn Zacharias, PhD, Executive Director, Research & Insights. Lumere, a GHX Company
Just as Sherlock Holmes relied on physical evidence to solve mysteries, modern-day supply chain leaders must use clinical evidence in the value analysis process to help make cost-effective, patient-focused product decisions.
As hospital leaders seek to reduce clinical spend while improving clinical outcomes and financial resiliency during the protracted COVID-19 pandemic, reliable evidence has never been more important. Supply chain professionals are feeling pressure to more rapidly gather and interpret clinical data and insights for frontline care teams – often without formal training in interpreting scientific literature.
Read More